NanoVation-GS

RPM and early exacerbations alert for optimal management of respiratory patients

Health Tech & Life Sciences
Non Active, Nov 2025 ceased to operate
Seed Haifa, Israel Founded 2014
LinkedIn
Last updated 2026-06-18
Total raised
$8.8M
Last: 2023-01
Stage
Seed
Founded
2014
Headcount
5
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

NanoVation-GS is a med-tech startup aiming to help alleviate the suffering of hundreds of millions of patients and reduce the high financial burden due to frequent hospitalizations of chronic respiratory patients such as COPD and asthma.

SenseGuard™, developed by NanoVation-GS, is a reliable and patient-friendly solution for monitoring patients’ respiratory condition, measuring unique lung function biomarkers from effortless (tidal) breathing. Short measurements of 2-3 minutes once a day, enable disease management and early detection and treatment of exacerbations, before they reach acute stage that requires hospitalization.

Funding history · 7 rounds · $8.8M total

2023-01
$750K
2020-07
Grant $2.8M
2017-01
2015-01
Grant $455K
2014-11

Q&A

What is NanoVation-GS's primary focus?
NanoVation-GS is a med-tech startup focused on developing solutions for monitoring respiratory conditions to help chronic respiratory patients like those with COPD and asthma, aiming to reduce hospitalizations.
What is the status of NanoVation-GS?
NanoVation-GS is currently inactive, having ceased operations in November 2025.
What is SenseGuard™?
SenseGuard™ is a product developed by NanoVation-GS for monitoring patients’ respiratory conditions by measuring lung function biomarkers from effortless breathing. It aims for early detection and treatment of exacerbations.
When was NanoVation-GS founded?
NanoVation-GS was founded in March 2014.
How many employees does NanoVation-GS have?
NanoVation-GS has 1-10 employees.
What is the total amount of funding raised by NanoVation-GS?
NanoVation-GS has raised a total of $8,755,000.
When was NanoVation-GS's most recent funding round and who participated?
NanoVation-GS's most recent funding round was in January 2023, with participation from ExitValley.
Who are the co-founders of NanoVation-GS?
The co-founders of NanoVation-GS are Gregory Shuster (CEO), Hossam Haick (CSO), and Nadav Bachar (CTO).

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDiagnostics DevicesDigital HealthcarePatient Remote Monitoring
Technologies
Materials & SubstancesNanomaterialsSensing
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance CompaniesPatients
Business model
B2B

Highlights

1 PatentsVerified

Tags

sensorsmedical-technologiesearly-detectionrespiratorynanotechnologydiagnosticsnon-invasivehome-caredecision-makingclinical-dataphysiological-parametershospitalspreventionwearabledigital-healthcareremote-monitoringmedical-devicesinsurance-companieschronic-patientsasthmawearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/86330280

Identifiers & details

Founded2014-3
Employees (exact)5
Status reasonNon Active, Nov 2025 ceased to operate